Fitbit Reports Second Quarter Results for the Three Months Ended June 29, 2019

26

Fitbit, Inc. reported revenue of $314 million, GAAP net loss per share of $(0.27), non-GAAP net loss per share of $(0.14), GAAP net loss of $(69) million, non-GAAP net loss of $(36) million, cash used in operations of $(76) million and free cash flow of $(81) million for its second quarter of 2019.

“While we are disappointed to lower guidance for the year, we remain confident in our long-term transformation strategy and have demonstrated good results across key areas of the business. We saw growth in devices sold, increased active users and continued growth in our Fitbit Health Solutions channel, up 42% in the first half of 2019,” said James Park, co-founder and CEO. “In addition, we have made progress in diversifying our revenue towards building more predictable, recurring revenue streams with the launch of our premium services in two test markets. We are pleased with the initial results and expect a full launch this fall. Coupled with innovative hardware and software offerings, we believe we’re well positioned to bring more users to the Fitbit platform and continue to grow our business.”

Second Quarter 2019

		For the Three Months Ended								For the Six Months Ended
In millions, except percentages and per share amounts		June 29, 2019				June 30, 2018				June 29, 2019				June 30, 2018
GAAP Results
Revenue		$	313.6			$	299.3			$	585.4			$	547.2
Gross Margin		34.5		%		39.8		%		33.8		%		42.6		%
Net Loss		$	(68.5	)		$	(118.3	)		$	(148.0	)		$	(199.1	)
Net Loss Per Share		$	(0.27	)		$	(0.49	)		$	(0.58	)		$	(0.83	)
Non-GAAP Results
Gross Margin		35.6		%		40.9		%		34.9		%		43.7		%
Net Loss		$	(35.8	)		$	(54.2	)		$	(73.8	)		$	(95.2	)
Net Loss Per Share		$	(0.14	)		$	(0.22	)		$	(0.29	)		$	(0.39	)
Adjusted EBITDA		$	(30.8	)		$	(55.8	)		$	(74.0	)		$	(102.0	)
Devices Sold		3.5				2.7				6.5				4.8

For additional information regarding the non-GAAP financial measures, see “Non-GAAP Financial Measures” and “Reconciliation of GAAP to Non-GAAP Financial Measures” below. Please note that certain terms used here, including “active user,” “activations,” and “repeat users,” are defined in our Annual Report on Form 10-K for the full year ended December 31, 2018 or our most recently filed Quarterly Report on Form 10-Q.

Second Quarter 2019 Financial Highlights

• Tracker revenue increased 51% year-over-year and represented 59% of revenue. Smartwatch revenue decreased 27% year-over-year, partly due to weaker than expected sales of Fitbit Versa Lite Edition^TM, and represented 38% of revenue. Accessory and non-device revenue represented 3% of revenue.
• Devices sold increased 31% year-over-year to 3.5 million. Average selling price decreased 19% year-over-year to $86 per device due to the introduction of more affordable devices, lowering the barriers to joining our community of active users.
• U.S. revenue represented 58% of total revenue or $181 million, down 1% year-over-year.
• International revenue represented 42% of total revenue and grew 14% to $133 million: EMEA revenue grew 33% to $88 million; Americas excluding U.S. revenue grew 21% to $19 million and APAC revenue declined 26% to $26 million (all on a year-over-year basis).
• New devices introduced in the past 12 months, Fitbit Charge 3^TM, Fitbit Inspire^TM, Fitbit Inspire HR^TM, Fitbit Ace 2^TM and Fitbit Versa Lite Edition^TM, represented 68% of revenue.
• GAAP gross margin was 34.5% and non-GAAP gross margin was 35.6%. Both GAAP and non-GAAP gross margin were negatively impacted by lower warranty benefit compared to the prior year and the reduction in average selling price, partially offset by an improvement in yield loss and efficiencies.
• GAAP operating expenses represented 57% of revenue, declining 18% year-over-year to $179 million, and non-GAAP operating expenses represented 51% revenue declining 18% year-over-year to $160 million.

Second Quarter 2019 Operational Highlights

• Tracker devices sold increased 56% year-over-year. Smartwatch devices sold decreased 7% year-over-year. Average selling price declined 19% year-over-year.
• Fitbit Health Solutions revenue grew 16% year-over-year, with strength overseas, and is on-track to deliver its full-year revenue of approximately $100 million.
• 41% of activations came from repeat users; of the repeat users, 53% came from users who were inactive for 90 days or more. Active users increased year-over-year.

Third Quarter 2019 Guidance

• We expect an increase in devices sold and a decline in average selling price, each year-over-year. We expect revenue to decline 15% to 10% year-over-year and to be in the range of $335 million to $355 million.
• We expect average selling price to improve from Q2 as we plan to shift our new product introduction cadence back to innovation from value.
• We expect non-GAAP gross margin to trend lower than Q2 driven by the increase in revenue mix towards smartwatches, higher hosting costs, and higher promotions.
• We expect non-GAAP operating expenses to remain relatively flat year-over-year.
• We expect non-GAAP basic net loss per share in the range of $(0.11) to $(0.09).
• We expect adjusted EBITDA to be in the range of a loss of $(27) million to $(19) million.
• We expect non-GAAP effective tax rate of approximately 25%.
• We expect stock-based compensation expense of approximately $19 million and basic share count of approximately 260 million.
• We expect capital expenditures as a percentage of revenue of approximately 5%.

Full Year 2019 Guidance

• We expect an increase in devices sold in 2019 and a decrease in average selling price, each year-over-year.
• With weaker Versa Lite sales, we are lowering the midpoint of our 2019 revenue guidance by $95 million to $1.455 billion from $1.550 billion and now expect full year 2019 revenue to be $1.43 billion to $1.48 billion.
• We expect non-GAAP gross margin to be approximately 35% for the full year 2019, down from approximately 40% as previously expected, due to a decrease in revenue, higher returns and E&O costs, and higher promotions.
• We are reducing our non-GAAP operating expense target to approximately $640 million from the previously forecasted range of $660 million to $690 million.
• We expect non-GAAP basic net loss per share in the range of $(0.38) to $(0.31).
• We expect adjusted EBITDA to be in the range of $(85) million to $(60) million.
• We expect non-GAAP effective tax rate of approximately 25%. We expect non-GAAP effective tax rate to be volatile driven by geographic mix of revenue, tax credits, and our shift to profitability.
• We expect stock-based compensation expense of approximately $80 million and basic share count of approximately 260 million.
• Capital expenditures as a percentage of revenue of approximately 3%.
• With the year-over-year change in working capital anticipated to be less of a benefit in 2019 as compared to 2018, we expect free cash flow to be less than adjusted EBITDA, and in the range of approximately $(150) million to $(120) million.

For additional information regarding the non-GAAP financial measures presented above, see “Non-GAAP Financial Measures” below.

Webcast and Conference Call Information

Fitbit will host a conference call today at 5:00 p.m. Eastern Time, 2:00 p.m. Pacific Time, to discuss its results. Investors may access a live webcast of the call through the Investor section of Fitbit’s website at investor.fitbit.com. The call can also be accessed by dialing (800) 458-4148 or (929) 477-0324, access code 8960839. A replay of the call will be archived on Fitbit’s website for the following six months.

Forward Looking Statements

This press release contains forward-looking statements that involve risks and uncertainties, including statements regarding our outlook for the third quarter of 2019 and full year 2019 and all underlying assumptions; trends in revenues, devices sold, average selling price, product mix, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP net loss per share, adjusted EBITDA, non-GAAP effective tax rate and drivers, stock-based compensation expense, basic/diluted share count, capital expenditures, product returns, E&O costs, hosting costs, promotional activities, working capital, and free cash flow; expected Versa Lite sales, including impacts related to seasonality; growth in our Fitbit Health Solutions channel and non-device offerings and their associated revenue and impact on gross margins; growth of our user base; business strategies; introductions of new products and services, including timing of our premium and other software services and hardware offerings and their expected features and benefits; and retail and consumer demand for smartwatches and trackers; and all other statements that are not historical facts.

These forward-looking statements are only predictions and may differ materially from actual results due to a variety of factors, including: the effects of the highly competitive market in which we operate, including competition from much larger technology companies; our ability to anticipate and satisfy consumer preferences in a timely and cost-effective manner; our ability to successfully develop, timely introduce, and achieve retail and customer acceptance of new products and services, or enhance existing products and services, including software and subscription services; our ability to accurately forecast consumer demand and adequately manage our inventory; our ability to ship products on the timelines we anticipate and avoid unexpected delays; our ability to detect, prevent or fix quality issues in our products and services; our ability to attract and retain employees; our reliance on third-party suppliers, contract manufacturers, and logistics providers and our limited control over such parties; delays in procuring components and product from third parties or their suppliers; the ability of third parties to successfully manufacture and ship quality products in a timely manner; seasonality of demand; the concentrated nature of our retailer and distributor base; product liability issues, security breaches or other defects that may adversely affect product performance and overall market acceptance of our products and services; our ability to integrate acquired technologies and employees of acquired businesses into our operations, particularly in new geographies; warranty claims; the relatively new and unproven market for trackers and wearable devices; the ability of our channel partners to sell our products; litigation and related costs; the impact of privacy and data security laws; changes in tax laws; the impact of tariffs; and other general market, political, economic and business conditions.

Additional risks and uncertainties that could affect our financial results are included under the caption “Risk Factors” in our Annual Report on Form 10-K for the full year ended December 31, 2018 and our most recently filed Quarterly Report on Form 10-Q which are available on our Investor Relations website at investor.fitbit.com and on the Securities and Exchange Commission (SEC) website at www.sec.gov. Once filed with the SEC, additional information will be set forth in our Quarterly Report on Form 10-Q for the quarter ended June 29, 2019. All forward-looking statements contained herein are based on information available to us as of the date hereof and we do not assume any obligation to update these statements as a result of new information or future events. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements and you should not place undue reliance on such statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments we may make.

Disclosure of Material Information

Fitbit announces material information to its investors using SEC filings, press releases, public conference calls and on its Investor Relations page on the company’s website at http://investor.fitbit.com.

Non-GAAP Financial Measures

To supplement our consolidated financial statements, which are prepared and presented in accordance with GAAP, we use the following non-GAAP financial measures in this press release: non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating income (loss), non-GAAP operating income (loss) before income taxes, non-GAAP net income (loss), non-GAAP basic/diluted net income (loss) per share, non-GAAP free cash flow, effective non-GAAP tax rate, non-GAAP research and development expenses, non-GAAP sales and marketing expenses, non-GAAP general and administrative expenses, and adjusted EBITDA. The presentation of these financial measures is not intended to be considered in isolation or as a substitute for, or superior to, financial information prepared and presented in accordance with GAAP.

We use non-GAAP measures to internally evaluate and analyze financial results. We believe these non-GAAP financial measures provide investors with useful supplemental information about the financial performance of our business, enable comparison of financial results between periods where certain items may vary independent of business performance, and enable comparison of our financial results with other public companies, many of which present similar non-GAAP financial measures.

There are limitations associated with the use of non-GAAP financial measures as an analytical tool. In particular, many of the adjustments to our GAAP financial measures reflect the exclusion of certain items, specifically stock-based compensation expense, depreciation, amortization of intangible assets, interest income, net, and the related income tax effects of the aforementioned exclusions, that are recurring and will be reflected in our financial results for the foreseeable future. In addition, these measures may be different from non-GAAP financial measures used by other companies, limiting their usefulness for comparison purposes. A reconciliation of our non-GAAP financial measures to their most directly comparable GAAP measures has been provided in the financial statement tables included in this press release, and investors are encouraged to review the reconciliation.

Guidance for non-GAAP financial measures excludes stock-based compensation, impact of restructuring, amortization of acquired intangible assets, and tax effects associated with these items. We have not reconciled guidance for non-GAAP financial measures to their most directly comparable GAAP measures because certain items that impact these measures are uncertain, out of our control, and/or cannot be reasonably predicted. Accordingly, a reconciliation of the non-GAAP financial measure guidance to the corresponding GAAP measures is not available without unreasonable effort.

The following are explanations of the adjustments that are reflected in one or more of our non-GAAP financial measures:

• Stock-based compensation expense relates to equity awards granted primarily to our employees. We exclude stock-based compensation expense because we believe that the non-GAAP financial measures excluding this item provide meaningful supplemental information regarding operational performance. In particular, companies calculate stock-based compensation expense using a variety of valuation methodologies and subjective assumptions.
• Restructuring costs primarily included severance-related costs. We believe that excluding this expense provides greater visibility to the underlying performance of our business operations, facilitates comparison of our results with other periods, and may also facilitate comparison with the results of other companies in our industry.
• Litigation expense relates to legal costs incurred due to litigation with Aliphcom, Inc. d/b/a Jawbone. We exclude these expenses because we do not believe they have a direct correlation to the operations of our business and because of the singular nature of the claims underlying the Jawbone litigation matters.
• Amortization of intangible assets relates to our acquisitions of FitStar, Pebble, Vector and Twine Health. We exclude these amortization expenses because we do not believe they have a direct correlation to the operation of our business.
• Income tax effect of non-GAAP adjustments relates to the tax effect of the adjustments that we incorporate into non-GAAP financial measures such as stock-based compensation, amortization of intangibles, restructuring and valuation allowance in order to provide a more meaningful measure of non-GAAP net loss.
• We define free cash flow as net cash provided by (used in) operating activities adjusted for purchase of property and equipment. We consider free cash flow to be a liquidity measure that provides useful information to management and investors about the amount of cash generated by the business that can possibly be used for investing in our business and strengthening the balance sheet, but it is not intended to represent the residual cash flow available for discretionary expenditures.